<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
        <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
        <title>Pharmacology - Drug Interactions</title>
        <meta name="viewport" content="width=device-width">

        <!-- syntax highlighting CSS -->
        <link rel="stylesheet" href="/css/syntax.css">

        <!-- Custom CSS -->
        <link rel="stylesheet" href="/css/main.css">

		<!-- Set refresh timer for local development -->
		
    </head>
    <body>

        <div class="container">
          <div class="site">

			<h1>Pharmacology - Drug Interactions</h1>
			<p class="meta">26 Nov 2013</p>

			<div class="post">
			<h3 id='summation_additivity'>Summation (Additivity)</h3>

<ul>
<li>The effect of two drugs given simultaneously is equal to the sum of their individual effects.</li>
</ul>
<span><br /></span>
<h3 id='potentiation_synergism'>Potentiation (Synergism)</h3>

<ul>
<li>The effect of two drugs is greater than the sum of their individual effects</li>
</ul>
<span><br /></span>
<h3 id='antagonism'>Antagonism</h3>

<ul>
<li>The effect of two drugs is less than the sum of their individual effects</li>
</ul>
<span><br /></span>
<h2 id='types_of_antagonism'>Types of Antagonism</h2>

<ul>
<li>
<p>Non-pharmacological or physical antagonism</p>

<ul>
<li>Activated charcoal for adsorption of a toxin</li>

<li>Chelation of heavy metals</li>

<li>Opposing effects at distinct sites: (e.g. NE vs. histamine on blood pressure)</li>
</ul>
</li>

<li>
<p>Pharmacological antagonism</p>

<ul>
<li>Two drugs interact either <em>directly</em> or <em>indirectly</em> with a common receptor to produce a net diminished effect.</li>

<li><strong>agonist</strong>: a drug which has affinity for a receptor, and intrinsic activity at that receptor</li>

<li><strong>antagonist</strong>: a drug which has affinity for a receptor but has no intrinsic activity</li>

<li>Formation of the antagonist-receptor complex does not produce a pharmacological response</li>

<li><strong>surmountable antagonism</strong> - &#8220;reversible,&#8221; &#8220;competitive&#8221; model</li>

<li><strong>insurmountable antagonism</strong> - formation of covalent bonds</li>
</ul>
</li>
</ul>
<div style='text-align:center;'>
<p><img alt='' src='/assets/antagonism-allosterism-model.png' /></p>
</div>
<h3 id='partial_agonists'>Partial Agonists</h3>

<ul>
<li><strong>partial agonist</strong>: a drug whose intrinsic activity is &gt; 0.0 but &lt; 1.0</li>

<li>Depending on the circumstances, a partial agonist may exhibit the properties of either an agonist or antagonist</li>

<li><strong>Suboxone = buprenorphine + naloxone</strong>: What is the rationale for combining a partial agonist and antagonist?</li>
</ul>
<span><br /></span>
<h3 id='inverse_agonists_and_constitutively_active_systems'>Inverse Agonists and Constitutively Active Systems</h3>

<ul>
<li>Chloride channel example: default state pore diameter approximately equal to diameter of chloride ion, normal flux.</li>

<li>Addition of <strong>agonist</strong> causes decreased pore diameter, thus decreased chloride ion flux</li>

<li>Addition of <strong>inverse agonist</strong>* causes increased pore diameter, thus increased chloride ion flux</li>
</ul>
<span><br /></span>
<h3 id='therapeutic_index'>Therapeutic Index</h3>

<ul>
<li><strong>Selectivity</strong>: The degree to which a drug acts upon a given site relative to all possible sites of interaction</li>

<li><strong>Therapeutic Index</strong>: ratio of the dose which produces toxic effects and the dose which produces the desired therapeutic effect</li>

<li>The therapeutic index provides a quantitative assessment of the relative benefits and risks of a drug</li>
</ul>
<div style='text-align:center;'>
<p><img alt='' src='/assets/therapeutic-effect-fluphenazine.png' /></p>
</div><span><br /></span>
<h3 id='multiple_therapeutic_indices'>Multiple Therapeutic Indices</h3>
<div style='text-align:center;'>
<p><img alt='' src='/assets/multiple-therapeutic-indices.png' /></p>
</div>
<h3 id='heterogeneity_of_the_patient_population'>Heterogeneity of the Patient Population</h3>

<ul>
<li>Log-dose response curve as a cumulative normal frequency distribution of sensitivities of the individual responsive units</li>

<li>You can choose a linear or semi-logarithmic scale to plot the data; either way: find the x-intercept of 50% on Y-axis, this will give you K<sub>D</sub> = [X]</li>
</ul>
<div style='text-align:center;'>
<p><img alt='' src='/assets/log-dose-response-curve.png' /></p>
</div>
			</div>
			<br>
			<hr>
            <div class="footer">
			<h6><p><a href="/">&#60; Back</a></p></h6>
			</div>
           	<div class="contact">
                <p>
					<a href="http://bquarant.github.io/">bquarant.github.io</a> | 2013 
               </p>
              </div>
          </div>
        </div>

<!-- Track traffic on gaug.es-->
		<script type="text/javascript">
		  var _gauges = _gauges || [];
		  (function() {
		    var t   = document.createElement('script');
		    t.type  = 'text/javascript';
		    t.async = true;
		    t.id    = 'gauges-tracker';
		    t.setAttribute('data-site-id', '51f19a5df5a1f51079000024');
		    t.src = '//secure.gaug.es/track.js';
		    var s = document.getElementsByTagName('script')[0];
		    s.parentNode.insertBefore(t, s);
		  })();
		</script>
    </body>
</html>